Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-28

Clinical Trial Update: First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

The document reports completion of a first-in-human Phase 1b/2a trial of a multipeptide therapeutic vaccine for progressive glioblastoma, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Multipeptide therapeutic vaccine

Snippet

Sponsor: Enterome | Conditions: Glioblastoma, Adult | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-11-28